RESEARCH PAPER
Possibility of pain reduction by dietary intervention in patients with advanced cancer
 
More details
Hide details
1
Maria Skłodowska-Curie Institute of Oncology, Department of Chemotherapy, Nutrition Support Team, Warsaw, Poland
2
Faculty of Human Nutrition and Consumer Sciences, Department of Dietetics, University of Life Sciences, Warsaw, Poland
CORRESPONDING AUTHOR
Ewa Lange
Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, W.K. Roentgena 5, 02-781 Warszawa, Poland
 
Ann Agric Environ Med. 2013;20(Special Issue 1):18–22
KEYWORDS
ABSTRACT
Pain in advanced cancer can have many causes, and they are not necessarily associated with the presence of cancer. Invalid daily food rations in terms of energy, nutritional value, and cooking techniques used can ignificantly impair quality of life, increase patients’ pain and other somatic symptoms and aggravate alnutrition and cachexia. Basic dietary factors affecting the quality of life and severity of somatic symptoms are the nutritional value of the diet, the frequency of meals and their consistency, the presence of fiber, fat, sugars, lactose, gluten and nutraceuticals. Extremely important is the role of a team of specialists, that offers professional nutritional advice to the patients and their carers.
 
REFERENCES (36)
1.
Nekolaichuk CL, Fainsinger RL, Aass N, Hjermstad MJ, Knudsen AK, Klepstad P, Currow DC, Kaasa S. For the European Palliative Care Research Collaborative (EPCRC). The Edmonton Classification System for Cancer Pain: Comparison of Pain Classification Features and Pain Intensity Across Diverse Palliative Care Settings in Eight Countries. J Palliat Med. 2013; 16(5): 516–523.
 
2.
DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980; 69 (4): 491–497.
 
3.
Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) „cachexiaanorexia in chronic wasting diseases” and „nutrition in geriatrics”. Clin Nutr. 2010; 29 (2): 154–159.
 
4.
Bonica JJ. Anatomic and physiologic basis of nocicepion and pain. In: Bonica JJ. The management of pain. Ed. 2. Lea & Febiger, Philadelphia, London 1990.p. 28–95.
 
5.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982; 50: 1913–1918.
 
6.
Stuver ShO, Isaac Th, Weeks JC, Block S, Berry DL, Davis RB, Weingart SN. Factors associated with pain among ambulatory patients with cancer with advanced disease at a Comprehensive Cancer Center. J Oncol Pract. 2012; 8(4): 17–23.
 
7.
Zhu J, Davis RB, Stuver ShO, Berry DL, Block S, Weeks JC, Weingart SN. A Longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer. 2012; 118: 6278–6286.
 
8.
Foley KM: Pain syndromes in patients with cancer. In: Bonica JJ, Ventafridda V (eds.), Advances in Pain Research and Therapy. Raven Press, New York 1979, 2: 59–78.
 
9.
Omlin A, Blum D, Wierecky J, Haile SR, Ottery FD, Strasser F. Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions,a case–control study. J Cachexia Sarcopenia Muscle. 2013; 4: 55–61.
 
10.
Jarosz J, Kapała A, Kłęk S, Misiak M, Bakinowska B., Czaplińska M., et al. Konferencja Uzgodnieniowa: Problemy żywieniowe w polskiej onkologii. Postępy Żywienia Klinicznego. 2012; 1: 29–38 (in Polish).
 
11.
Stratton RJ, Elia MA. A review of reviews: A new look at the evidence for oral nutritional supplements in clinical practice. Clin Nutr Suppl. 2007; 2(1): 5–23.
 
12.
Bourdel-Marchasson I, Barateau M, Rondeau V, Dequae-Merchadou L, Salles-Montaudon N, Emeriau J-P, et al. A multi-center trial of the effects of oral nutritional supplementation in critically ill older inpatients. Nutrition 2000; 16(1): 1–5.
 
13.
Spiro A, Baldwin C, Patterson A, Thomas J, Andreyev HJN, et al. The views and practise of oncologists towards nutritional support in patient receiving chemotherapy. Br J Cancer. 2006; 95(4): 431–434.
 
14.
Sobotka L (ed.). Basics In Clinical Nutrition. Techniques of nutritional support. 5th ed. ESPEN, Prague 2011.
 
15.
Arends J, Bodoky G, Bozzeti K, Fearon M, Muscaritoli G, Selga MAE, et al. ESPEN guidelines of enteral nutrition: non surgical oncology. Clin Nutr. 2006; 25(3): 245–259.
 
16.
Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurchere G, Muscaritolif M, et al. ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology. Clin Nutr. 2009; 28(4): 445–454.
 
17.
Roe JW, Leslie P, Drinnam MJ. Oropharyngeal dysphagia: the experience of patients with non-head and neck cancers receiving specialist palliative care. Palliat Med. 2007; 21(7): 567–574.
 
18.
Argilés JM, Busquets S, Toledo M, López-Soriano FJ. The role of cytokines in cancer cachexia. Curr Opi. Support Palliat Care. 2009; 3(4): 263–268.
 
19.
Van Bokhorst-de van der Scheuren MAE, von Blomberg-Van der Flier BME, Riezebos RK, Scholten PET, Quak JJ, Snow GB, van Leeuwen PAM. Differences in immune status between well-nourished and malnourished head and neck cancer patients. Clin Nutr. 1998; 19(6): 437–444.
 
20.
Sánchez-Muñoz A, Pérez-Ruiz E, Sáez MI, Trigo JM, Galindo MM, Manzaneque L, Jiménez B, Muros B, Alba E. Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status. Clin Transl Oncol. 2011; 13(6): 426–429.
 
21.
Ravasco P, Monteiro Grillo I, Maria C. Cancer wasting and quality of life react to individualised nutritional counseling. Clin Nutr. 2007; 26 (1): 7–15.
 
22.
Robison J, DuPen S, Stillman M, Fredrickson M, Rivkin S, Feldman E, Gralow J, Rieke JW, Raish RJ, Lee DJ, Cleeland ChS, DuPen A, Syrjala KL, Abrams JR, Polissar NL, Hansberry J. Patient training in cancer pain management using integrated print and video materials: A multisite randomized controlled trial. Pain. 2008; 135: 175–186.
 
23.
Capozzi LC, Lau H, Reimer RA, McNeely M, Giese-Davis J, CulosReed SN: Exercise and nutrition for head and neck cancer patients: a patient oriented, clinic-supported randomized controlled trial. Cancer 2012; 12: 446–454.
 
24.
Power J. Fact Sheet 14: If your bowel is blocked. London 2009. http:// www.ovacome.org.uk (access: 26.11.2013).
 
25.
Xue H, Sawyer MB, Wischmeyer PE, Baracos VE. Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. J Parenter Enteral Nutr. 2011; 35: 74–90.
 
26.
Hutton JL Martin L, Field CJ, Wismer WV, Bruera ED, Watanabe ShM, Baracos VE. Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy. Am J Clin Nutr. 2006; 84: 1163–1170.
 
27.
Hutyra T, Iwańczak B. Nietolerancja laktozy: patofizjologia, objawy kliniczne, rozpoznanie i leczenie. Pol Merk Lek. 2009; 36(152): 148–152 (in Polish).
 
28.
Wedlakea L, Thomasb K, McGougha C, Andreyevc HJN. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study. Eur J Cancer. 2008; 44(15): 2212–2217.
 
29.
Benson AB, Jaffer A, Ajani A, Catalano RB, Engelking C, Kornblau SM. Recommended guidelines for the treatment of cancer treatmentinduced diarrhea. J Clin Oncol. 2004; 22(14): 2918–2925.
 
30.
Delia P, Sansotta G, Donato P, Frosina P, Messina G, De Renzis C, Famularo G, et al. Use of probiotics for prevention of radiation-induced diarrhoea. World Journal of Gastroenterology 2007; 13(6): 912–915.
 
31.
Jervoise H, Andreyev N, Davidson SE, Gillespie C, Allum WH, Swarbrick E: Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012; 61: 179–192.
 
32.
Hardman WE. (n-3) Fatty Acids and Cancer Therapy. J Nutr. 2004; 134: 3427S–3430S.
 
33.
Laviano A, Rianda S, Molfino A, Fanelli FR. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care. 2013; 16(2): 156–161.
 
34.
Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res. 2012; 43(5): 356–362.
 
35.
Nakamoto K, Nishinaka T, Matsumoto K, Kasuya F, Mankura M, Koyama Y, Tokuyama S. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system. Brain Res. 2012; 13(1432): 74–83.
 
36.
Schloss JM, Colosimo M, Airey C. Masci PP, Linnane AW, Vitetta L. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review. Clin Nutr. 2013 http://dx.doi.org/10.1016/j. clnu (access: 2013.04.07).
 
eISSN:1898-2263
ISSN:1232-1966